| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 136, 5127-5134, Copyright © 1995 by Endocrine Society
ARTICLES |
IU Schmidt, H Dobnig and RT Turner
Department of Orthopedics, Mayo Clinic, Rochester, Minnesota 55905, USA.
The effects of GH and PTH on cancellous histomorphometry were determined in the proximal tibial metaphysis of hypophysectomized (HYPOX) sexually mature female rats. HYPOX resulted in uterine atrophy and a loss in body weight. Longitudinal bone growth ceased and bone formation was greatly reduced. There were decreases in cancellous bone area, trabecular number, and trabecular thickness. Intermittent treatment with GH did not influence uterine weight in HYPOX rats. However, GH resulted in resumption of whole body weight gain, as well as maintenance of normal longitudinal bone growth. Additionally, GH partially maintained bone formation in HY POX rats and did not have a significant effect on steady state messenger RNA levels for osteocalcin. Intermittent treatment with PTH had no effect on whole body weight gain, uterine weight, or longitudinal bone growth. In contrast, PTH increased bone formation compared with the baseline, HYPOX, and GH-treated HYPOX rats, and dramatically increased osteocalcin messenger RNA levels compared with the latter two groups. The increased bone formation was primarily due to an increase in osteoblast number; the mineral apposition rate, an index of osteoblast activity, was increased compared with control and GH-treated rats but not compared with baseline values. Interestingly, neither treatment influenced indices of bone resorption.
This article has been cited by other articles:
![]() |
D. Merciris, C. Marty, C. Collet, M.-C. de Vernejoul, and V. Geoffroy Overexpression of the Transcriptional Factor Runx2 in Osteoblasts Abolishes the Anabolic Effect of Parathyroid Hormone in Vivo Am. J. Pathol., May 1, 2007; 170(5): 1676 - 1685. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Q. Pirih, A. Tang, I. C. Ozkurt, J. M. Nervina, and S. Tetradis Nuclear Orphan Receptor Nurr1 Directly Transactivates the Osteocalcin Gene in Osteoblasts J. Biol. Chem., December 17, 2004; 279(51): 53167 - 53174. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Ahmed, D. Gesty-Palmer, M. K. Drezner, and L. M. Luttrell Transactivation of the Epidermal Growth Factor Receptor Mediates Parathyroid Hormone and Prostaglandin F2{alpha}-Stimulated Mitogen-Activated Protein Kinase Activation in Cultured Transgenic Murine Osteoblasts Mol. Endocrinol., August 1, 2003; 17(8): 1607 - 1621. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Krishnan, T. L. Moore, Y. L. Ma, L. M. Helvering, C. A. Frolik, K. M. Valasek, P. Ducy, and A. G. Geiser Parathyroid Hormone Bone Anabolic Action Requires Cbfa1/Runx2-Dependent Signaling Mol. Endocrinol., March 1, 2003; 17(3): 423 - 435. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Vahle, M. Sato, G. G. Long, J. K. Young, P. C. Francis, J. A. Engelhardt, M. S. Westmore, Y. L. Ma, and J. B. Nold Skeletal Changes in Rats Given Daily Subcutaneous Injections of Recombinant Human Parathyroid Hormone (1-34) for 2 Years and Relevance to Human Safety Toxicol Pathol, April 1, 2002; 30(3): 312 - 321. [Abstract] [PDF] |
||||
![]() |
N. Miyakoshi, Y. Kasukawa, T. A. Linkhart, D. J. Baylink, and S. Mohan Evidence That Anabolic Effects of PTH on Bone Require IGF-I in Growing Mice Endocrinology, October 1, 2001; 142(10): 4349 - 4356. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. L. Ma, R. L. Cain, D. L. Halladay, X. Yang, Q. Zeng, R. R. Miles, S. Chandrasekhar, T. J. Martin, and J. E. Onyia Catabolic Effects of Continuous Human PTH (1-38) in Vivo Is Associated with Sustained Stimulation of RANKL and Inhibition of Osteoprotegerin and Gene-Associated Bone Formation Endocrinology, September 1, 2001; 142(9): 4047 - 4054. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.G. Young, H. Li, Y. Xiao, M.J. Waters, and P.M. Bartold Growth-hormone-stimulated Dentinogenesis in Lewis Dwarf Rat Molars Journal of Dental Research, August 1, 2001; 80(8): 1742 - 1747. [Abstract] [PDF] |
||||
![]() |
R. R. Miles, J. P. Sluka, D. L. Halladay, R. F. Santerre, L. V. Hale, L. Bloem, K. Thirunavukkarasu, R. J. S. Galvin, J. M. Hock, and J. E. Onyia ADAMTS-1: A Cellular Disintegrin and Metalloprotease with Thrombospondin Motifs Is a Target for Parathyroid Hormone in Bone Endocrinology, December 1, 2000; 141(12): 4533 - 4542. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Soma, S. Matsumoto, Y. Higuchi, T. Takano-Yamamoto, K. Yamashita, K. Kurisu, and M. Iwamoto Local and Chronic Application of PTH Accelerates Tooth Movement in Rats Journal of Dental Research, September 1, 2000; 79(9): 1717 - 1724. [Abstract] [PDF] |
||||
![]() |
M. Amling, M. Priemel, T. Holzmann, K. Chapin, J. M. Rueger, R. Baron, and M. B. Demay Rescue of the Skeletal Phenotype of Vitamin D Receptor-Ablated Mice in the Setting of Normal Mineral Ion Homeostasis: Formal Histomorphometric and Biomechanical Analyses Endocrinology, November 1, 1999; 140(11): 4982 - 4987. [Abstract] [Full Text] |
||||
![]() |
J. K. Yeh, J. F. Evans, M.-M. Chen, and J. F. Aloia Effect of hypophysectomy on the proliferation and differentiation of rat bone marrow stromal cells Am J Physiol Endocrinol Metab, January 1, 1999; 276(1): E34 - E42. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ohlsson, B.-A. Bengtsson, O. G. P. Isaksson, T. T. Andreassen, and M. C. Slootweg Growth Hormone and Bone Endocr. Rev., February 1, 1998; 19(1): 55 - 79. [Abstract] [Full Text] |
||||
![]() |
K. C. Westerlind, J. D. Fluckey, S. E. Gordon, W. J. Kraemer, P. A. Farrell, and R. T. Turner Effect of resistance exercise training on cortical and cancellous bone in mature male rats J Appl Physiol, February 1, 1998; 84(2): 459 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Dobnig and R. T. Turner The Effects of Programmed Administration of Human Parathyroid Hormone Fragment (1-34) on Bone Histomorphometry and Serum Chemistry in Rats Endocrinology, November 1, 1997; 138(11): 4607 - 4612. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Yeh, M.-M. Chen, and J. F. Aloia Effects of estrogen and growth hormone on skeleton in the ovariectomized rat with hypophysectomy Am J Physiol Endocrinol Metab, October 1, 1997; 273(4): E734 - E742. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |